GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Endoscopy/EUS-FNAB for Solid Pancreatic Lesions: GIE | July 2026

EUS-FNAB for Solid Pancreatic Lesions: GIE | July 2026

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated July 1, 2026

Quick Answer

Introduction: Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is the standard technique for diagnosing solid pancreatic lesions. Traditionally, biopsy specimens are processed for cytology, often requiring on-site cytopathology support.


Introduction:

Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is the standard technique for diagnosing solid pancreatic lesions. Traditionally, biopsy specimens are processed for cytology, often requiring on-site cytopathology support. This multicenter prospective study evaluated whether directly placing FNB tissue in formalin for histopathology could provide comparable diagnostic performance.

Why was this study needed?

  • Many centers lack rapid on-site cytopathology (ROSE) or dedicated cytopathologists.
  • Histopathology may better preserve tissue architecture for diagnosis and ancillary testing.
  • The optimal processing method for EUS-FNB specimens remains uncertain.
  • Simplifying specimen handling could improve workflow and reduce procedure time.
  • Prospective data comparing histopathology with conventional cytology are limited.

Results:

  • Histopathologic evaluation of EUS-FNB specimens achieved diagnostic accuracy comparable to conventional cytology for solid pancreatic lesions.
  • Histopathology required fewer needle passes, potentially reducing procedure time and improving efficiency.
  • With macroscopic on-site evaluation (MOSE), all histopathology specimens were adequate for analysis, supporting its reliability even without on-site cytopathologists.

Clinical Impact:

This study supports direct formalin submission of EUS-FNB specimens for histopathology as a practical alternative to cytology, particularly in centers without ROSE or cytopathology services. It may simplify specimen processing while maintaining excellent diagnostic performance.

Bottom Line:

Histopathology with MOSE is a reliable alternative to cytology for EUS-FNB of solid pancreatic lesions. It provides comparable diagnostic accuracy with fewer needle passes, making it an attractive approach for routine clinical practice, especially in resource-limited settings.

Related Q&A

Duodenal Mucosal Resurfacing REMAIN-1 Study: DDW | 2026

Introduction: Obesity has become one of the greatest global health challenges. New incretin-based therapies—including semaglutide, tirzepatide, resmetirom, and SGLT2 inhibitors such as empagliflozin—have transformed the treatment of obesity, diabetes, and MASLD. However, many patients discontinue...

Durable Endoscopic Partial Reversal of Roux-en-Y Gastric Bypass Using Parallel LAMS Septotomy: GIE | July 2026

Introduction: Although Roux-en-Y gastric bypass (RYGB) is an effective bariatric procedure, a small proportion of patients develop severe nutritional complications, refractory dumping syndrome, or other debilitating adverse events requiring reversal. This study describes a novel...

EUS Double Drainage for Malignant Dual Obstruction : Gut | Jul 2026

Introduction: Simultaneous malignant distal biliary obstruction (MDBO) and gastric outlet obstruction (GOO), commonly caused by advanced pancreatic, biliary, or duodenal cancers, presents a major palliative challenge. Conventional endoscopic approaches often require repeated interventions and may...

Endoscopic Mucosal and Submucosal Cutting in benign esophageal stricture: Gut | July 2026

Introduction: Long benign esophageal strictures remain one of the most difficult benign conditions to manage. Although endoscopic dilation and incision techniques provide temporary relief, recurrence is common, often requiring repeated interventions. This study introduces a...

Economic Impact of POEM and ESD: GIE | June 2026

Introduction: Peroral endoscopic myotomy (POEM) and endoscopic submucosal dissection (ESD) have revolutionized the management of esophageal motility disorders and early gastrointestinal neoplasia. Despite their proven clinical benefits, widespread adoption has been limited by concerns regarding...

Remimazolam Improves Sedation Safety During ERCP : GIE | Jun 2026

Introduction: Deep sedation is essential for successful endoscopic retrograde cholangiopancreatography (ERCP), a technically complex procedure frequently performed in elderly patients and those with significant comorbidities. Propofol remains the most commonly used sedative agent because of...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer